Austin Health

Title
Cross-priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon.
Publication Date
2004-01-01
Author(s)
Chen, Weisan
Masterman, Kelly-Anne
Basta, Sameh
Haeryfar, S M Mansour
Dimopoulos, Nektaria
Knowles, Barbara
Bennink, Jack R
Yewdell, Jonathan W
Type of document
Journal Article
DOI
10.1002/eji.200324257
Abstract
"Cross-priming" refers to the activation of naive CD8+ T cells by antigen-presenting cells that have acquired nominal antigens from another cell. The biological relevance of cross-priming of CD8+ T cells has recently been challenged (Zinkernagel, R. M., Eur. J. Immunol. 2002. 32: 2385-2392), on the basis that responses are weak or poorly quantitated, and the determinants recognized are undefined. Here we show that cross-priming is a robust process that elicits vigorous primary responses to multiple peptides in two well-defined systems. Our findings support the relevance of cross-priming in CD8+ T cell responses to viruses and tumor cells, and demonstrate that cross-priming elicits CD8+ T cells to determinants generated by the endogenous processing pathway.
Link
Citation
European Journal of Immunology; 34(1): 194-9
Jornal Title
European journal of immunology

Files:

NameSizeformatDescriptionLink